Showing results (101-110 of 115) with videos related to
Sort By:
Pageof 12
Clinical Nutrition (Edinburgh, Scotland)|August 6, 2019
Creatinine synthesis rate and muscle strength and self-reported physical health in dialysis patientsEnya S J M Poppe, Harmke A Polinder-Bos, Marleen Huberts, et al.Environmental Management|November 19, 2017
Assessing Restoration Effects on River Hydromorphology Using the Process-based Morphological Quality Index in Eight European River ReachesB Belletti, L Nardi, M Rinaldi, et al.International Journal of Radiation Oncology, Biology, Physics|July 15, 2023
Kidney Disease in Childhood Cancer Survivors Treated With Radiation Therapy: A PENTEC Comprehensive ReviewMatthew M Poppe, An Tai, X Allen Li, et al.Critical Care Medicine|November 18, 2014
Individualized early goal-directed therapy in systemic inflammation: is full utilization of preload reserve the optimal strategy?Karin H Wodack, Annika M Poppe, Lena Tomkötter, et al.Obesity Reviews : an Official Journal of the International Association for the Study of Obesity|September 28, 2018
Effects of health at every size® interventions on health-related outcomes of people with overweight and obesity: a systematic reviewM D Ulian, L Aburad, M S da Silva Oliveira, et al.Cancer|August 2, 2022
Mental health disorders are more common in patients with Hodgkin lymphoma and may negatively impact overall survivalRanda Tao, Yuji Chen, Seungmin Kim, et al.Journal of Virology|June 1, 1996
(Alkylamino) piperidine bis(heteroaryl)piperizine analogs are potent, broad-spectrum nonnucleoside reverse transcriptase inhibitors of drug-resistant isolates of human immunodeficiency virus type 1 (HIV-1) and select for drug-resistant variants of HIV-1IIIB with reduced replication phenotypesR A Olmsted, D E Slade, L A Kopta, et al.Brain : a Journal of Neurology|October 31, 2006
Proteome-based plasma biomarkers for Alzheimer's diseaseA Hye, S Lynham, M Thambisetty, et al.Journal of Medicinal Chemistry|September 28, 1998
Pyrimidine thioethers: a novel class of HIV-1 reverse transcriptase inhibitors with activity against BHAP-resistant HIVR A Nugent, S T Schlachter, M J Murphy, et al.Trials|July 26, 2022
The APPLE Tree programme: Active Prevention in People at risk of dementia through Lifestyle, bEhaviour change and Technology to build REsiliEnce-randomised controlled trialM Poppe, L Duffy, N L Marchant, et al.Pageof 12